Latest Investor Confidence News

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

Sunrise Energy Metals has raised A$32.5 million through a follow-on placement, advancing its flagship Syerston Scandium Project toward mid-2026 construction. This latest capital injection builds on a total of A$105 million raised since June 2025, underscoring strong investor confidence amid growing scandium demand.

Barton Gold Holdings has reported promising shallow, high-grade gold assay results from its Tunkillia project, reinforcing projections of $1.3 billion operating profit in the first 2.5 years. The company is on track for a resource upgrade and further drilling to refine its development plans.

Lake Resources has disclosed an inadvertent breach of ASX Listing Rule 7.1 related to the timing of share issuance under an agreement with Acuity Capital. The company is taking steps to strengthen governance and prevent future errors.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Winsome Resources Limited (ASX, WR1) has had its trading suspension lifted immediately following its response to an ASX price query, restoring market access for investors.

Biotron Limited’s BITO securities have been suspended from ASX trading due to non-compliance with key listing rules, raising questions about the company’s next steps.

Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.

Assetora Limited has raised $1.535 million through three placements, including a second investment from Creative Capital Management, to advance its alternative-asset platform.

Assetora Limited has updated its previous placement announcements, confirming that the issuance of shares to Cardio Link and Creative Capital Management will now require shareholder approval at an upcoming EGM likely scheduled for late January 2026.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

Alicanto Minerals has acknowledged a late filing of a director’s interest notice, attributing it to an administrative oversight. The ASX has queried the delay, prompting the company to review its disclosure procedures.